Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pujol

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Evolutionary Applications|October 24, 2024
When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian ClockMargaux Bieuville, Antoine M Dujon, Nynke Raven, et al.
Evolutionary Applications|February 5, 2026
Selection for Function in Complex Distributed Pathological SystemsFrédéric Thomas, Antoine M Dujon, Daniel Vaiman, et al.
Plos Biology|October 3, 2018
Is adaptive therapy natural?Frédéric Thomas, Emmanuel Donnadieu, Guillaume M Charriere, et al.
Evolution; International Journal of Organic Evolution|November 1, 2015
The guardians of inherited oncogenic vulnerabilitiesAudrey Arnal, Tazzio Tissot, Beata Ujvari, et al.
Evolutionary Applications|April 13, 2026
Selection for Function in Early Life: Implications for Early-Onset PathologiesKlara Asselin, Antoine M Dujon, Jean-Pascal Capp, et al.
Cancers|June 26, 2026
Diagnostic Challenges of Tumor Tissue and Circulating Microsatellite Status Assessment in Metastatic Colorectal Cancer and Their Impact on Access to Immunotherapy: A Real-World Retrospective StudyBenoist Chibaudel, Linda Dainese, Elisabeth Carola, et al.
Clinical Epigenetics|April 29, 2025
Reverse genotyping: unveiling Alu element insertion as a new cause of Kabuki syndrome using DNA methylation signatureQuentin Sabbagh, Nathalie Ruiz-Pallares, Cassandra Rastin, et al.
Oncogene|August 11, 2005
The nuclear receptor liver receptor homolog-1 is an estrogen receptor target geneJean-Sébastien Annicotte, Carine Chavey, Nadège Servant, et al.
Molecular Genetics & Genomic Medicine|October 1, 2019
Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?Marion Imbert-Bouteille, Marion Gauthier-Villars, Dominique Leroux, et al.
Evolution, Medicine, and Public Health|September 22, 2025
Leveraging selection for function in tumor evolution: System-level cancer therapiesFrédéric Thomas, Jean-Pascal Capp, Antoine M Dujon, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Evolutionary Applications|October 24, 2024
When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian ClockMargaux Bieuville, Antoine M Dujon, Nynke Raven, et al.
Evolutionary Applications|February 5, 2026
Selection for Function in Complex Distributed Pathological SystemsFrédéric Thomas, Antoine M Dujon, Daniel Vaiman, et al.
Plos Biology|October 3, 2018
Is adaptive therapy natural?Frédéric Thomas, Emmanuel Donnadieu, Guillaume M Charriere, et al.
Evolution; International Journal of Organic Evolution|November 1, 2015
The guardians of inherited oncogenic vulnerabilitiesAudrey Arnal, Tazzio Tissot, Beata Ujvari, et al.
Evolutionary Applications|April 13, 2026
Selection for Function in Early Life: Implications for Early-Onset PathologiesKlara Asselin, Antoine M Dujon, Jean-Pascal Capp, et al.
Cancers|June 26, 2026
Diagnostic Challenges of Tumor Tissue and Circulating Microsatellite Status Assessment in Metastatic Colorectal Cancer and Their Impact on Access to Immunotherapy: A Real-World Retrospective StudyBenoist Chibaudel, Linda Dainese, Elisabeth Carola, et al.
Clinical Epigenetics|April 29, 2025
Reverse genotyping: unveiling Alu element insertion as a new cause of Kabuki syndrome using DNA methylation signatureQuentin Sabbagh, Nathalie Ruiz-Pallares, Cassandra Rastin, et al.
Oncogene|August 11, 2005
The nuclear receptor liver receptor homolog-1 is an estrogen receptor target geneJean-Sébastien Annicotte, Carine Chavey, Nadège Servant, et al.
Molecular Genetics & Genomic Medicine|October 1, 2019
Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?Marion Imbert-Bouteille, Marion Gauthier-Villars, Dominique Leroux, et al.
Evolution, Medicine, and Public Health|September 22, 2025
Leveraging selection for function in tumor evolution: System-level cancer therapiesFrédéric Thomas, Jean-Pascal Capp, Antoine M Dujon, et al.
Pageof 10